CAR T

Views & Analysis
QandA-Sangamos-Duncan-McKay-on-genomic-medicines

Q&A: Sangamo’s Duncan McKay on genomic medicines

We talk to Duncan McKay, senior vice president and general manager, Europe of Sangamo Therapeutics, about the future of genomic medicines and how healthcare systems may need to adapt to

Videos
(651)-GIL-SP1-Cell-Therapy-Leadership-videos-BOTH-Feature-NEW

Building cell therapy leadership in Europe

In these videos, Markwin Velders and Louis van de Wiel of Kite, a Gilead Company, provide a behind the scenes insight into the company’s European operations, including building a new manufactur